Most people on GLP-1 drugs can safely fast for Yom Kippur or other religious observances, but they may need to plan ahead, take certain precautions or be ready to call it quits if they feel ill.
Articles on Wegovy
Displaying 1 - 20 of 73 articles
GLP-1 drugs can produce major weight loss, but their wider impact will depend on affordable treatment and appropriate support.
GLP-1 disclosure in dating is fraught and inconsistent largely due to the stigma around losing weight the “right way.”
Several studies suggest GLP-1 drugs may lower cancer risk. But that benefit may be due to the patients themselves: those who are healthier, wealthier and with better access to care.
Many people regain weight after stopping GLP-1 medicines. Long-term support may be as important as the drugs themselves.
New data shows obesity rising fastest among the young and the poor, while it’s mainly the better off who are seeing the benefit of weight-loss drugs.
Some research suggests between 10% and 30% of GLP-1 drug users may be considered non-responders.
Ozempic-style drugs have been flagged as possible treatments for cancer, dementia, endo, addiction and more. An expert explains what the evidence really says.
Orforglipron could help keep the weight off after people come off the expensive weight-loss jabs.
Yet another weight loss drug is causing a stir online. But health authorities and experts say it may bring more risks than rewards.
The thriving market in online, counterfeit GLP-1 drugs that do not meet FDA criteria poses serious risks to consumers.
In a clinical trial, this small-molecule drug was found to be superior to semaglutide for lowering blood sugar.
A major study links Wegovy to a rare form of sudden vision loss, and finds men may face three times the risk of women.
Appetite is governed by gut hormones, not willpower. GLP-1 therapies extend natural satiety signals and expose the biology behind eating.
Due to the body’s natural tendency to restore its former weight, many people regain their lost weight when they stop using GLP-1 drugs.
New weight loss jabs work brilliantly – but only while you’re taking them. The rebound is fast, and the cost-effectiveness unclear.
Millions are taking weight loss drugs like Wegovy. But what happens when you stop? Eggs might help fill the gap.
Australia’s regulator has issued warnings about the risk of suicidal thoughts and lower effectiveness of contraceptives in those taking Ozempic, Wegovy and Mounjaro.
The evolutionary science of weight regain unpacked.
Weight doesn’t tell us the whole story about a person’s risk for poor health.
Top contributors
-
Associate Professor of Metabolic Medicine, University of Surrey
-
Associate Professor of Physiology and Medical Education, Anglia Ruskin University
-
Professor of Health Service Operations, School of Pharmacy & Medical Sciences, University of Bradford
-
General Practitioner, PhD Candidate, Bond University
-
Research Lead/Advanced Clinical Practitioner/Senior Research Fellow, University of Bradford
-
Professor of Community Health and Wellbeing, The University of Queensland
-
Associate Professor in Pharmacy Practice, University of Bradford
-
Clinical Epidemiologist, Washington University in St. Louis
-
Accredited Practising Dietitian and Lecturer, Southern Cross University
-
Senior Lecturer, Pharmacy, Aston University
-
ARC Future Fellow, School of Biomedical Sciences, The University of Queensland
-
Associate Professor of Nutrition, University of Surrey
-
Professor of Pharmaceutical Chemistry, Macquarie University
-
Associate Professor of Gastroenterology, School of Medicine, University of Washington
-
Honorary Associate Professor, University of Leicester